Back to companies
Fulgent Genetics, Inc.
FLGTUSNASDAQPharmaceuticals & HealthcareFulgent Genetics, Inc.
Revenue
$322.7mn
YoY +13.8%
Operating income
-$91.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API